Reduced Levels of Vasopressin and Reduced Behavioral Modulation of Oxytocin in Psychotic Disorders
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Reduced Levels of Vasopressin and Reduced Behavioral Modulation of Oxytocin in Psychotic Disorders
Authors
Keywords
-
Journal
SCHIZOPHRENIA BULLETIN
Volume 40, Issue 6, Pages 1374-1384
Publisher
Oxford University Press (OUP)
Online
2014-03-12
DOI
10.1093/schbul/sbu027
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neuropsychological Impairments in Schizophrenia and Psychotic Bipolar Disorder: Findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) Study
- (2013) S. Kristian Hill et al. AMERICAN JOURNAL OF PSYCHIATRY
- Anatomical and Functional Brain Abnormalities in Drug-Naive First-Episode Schizophrenia
- (2013) Wenting Ren et al. AMERICAN JOURNAL OF PSYCHIATRY
- Clinical Phenotypes of Psychosis in the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP)
- (2013) Carol A. Tamminga et al. AMERICAN JOURNAL OF PSYCHIATRY
- May oxytocin be a trait marker for bipolar disorder?
- (2013) Tayfun Turan et al. PSYCHONEUROENDOCRINOLOGY
- Peripheral vasopressin but not oxytocin relates to severity of acute psychosis in women with acutely-ill untreated first-episode psychosis
- (2013) Leah H. Rubin et al. SCHIZOPHRENIA RESEARCH
- Effects of single dose intranasal oxytocin on social cognition in schizophrenia
- (2013) Michael C. Davis et al. SCHIZOPHRENIA RESEARCH
- Helping oxytocin deliver: considerations in the development of oxytocin-based therapeutics for brain disorders
- (2013) K. MacDonald et al. Frontiers in Neuroscience
- Characterization of the effects of oxytocin on fear recognition in patients with schizophrenia and in healthy controls
- (2013) Meytal Fischer-Shofty et al. Frontiers in Neuroscience
- Intranasal Oxytocin as an Adjunct to Risperidone in Patients with Schizophrenia
- (2012) Amirhossein Modabbernia et al. CNS DRUGS
- Volumetric hemispheric ratio as a useful tool in personality psychology
- (2012) Christian Montag et al. NEUROSCIENCE RESEARCH
- Stress abnormalities in individuals at risk for psychosis: A review of studies in subjects with familial risk or with “at risk” mental state
- (2012) Giuliano Aiello et al. PSYCHONEUROENDOCRINOLOGY
- Adjunctive intranasal oxytocin improves verbal memory in people with schizophrenia
- (2012) David Feifel et al. SCHIZOPHRENIA RESEARCH
- Is oxytocin a promising treatment for schizophrenia?
- (2011) David Feifel Expert Review of Neurotherapeutics
- The contributions of oxytocin and vasopressin pathway genes to human behavior
- (2011) Richard P. Ebstein et al. HORMONES AND BEHAVIOR
- Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine
- (2011) Andreas Meyer-Lindenberg et al. NATURE REVIEWS NEUROSCIENCE
- Oxytocin as a Potential Therapeutic Target for Schizophrenia and Other Neuropsychiatric Conditions
- (2011) David Feifel NEUROPSYCHOPHARMACOLOGY
- Divergent effects of two different doses of intranasal oxytocin on facial affect discrimination in schizophrenic patients with and without polydipsia
- (2011) Morris B. Goldman et al. PSYCHOPHARMACOLOGY
- Sex-specific associations between peripheral oxytocin and emotion perception in schizophrenia
- (2011) Leah H. Rubin et al. SCHIZOPHRENIA RESEARCH
- Intranasal oxytocin reduces psychotic symptoms and improves Theory of Mind and social perception in schizophrenia
- (2011) Cort A. Pedersen et al. SCHIZOPHRENIA RESEARCH
- The Hippocampal Formation in Schizophrenia
- (2010) Carol A. Tamminga et al. AMERICAN JOURNAL OF PSYCHIATRY
- Adjunctive Intranasal Oxytocin Reduces Symptoms in Schizophrenia Patients
- (2010) David Feifel et al. BIOLOGICAL PSYCHIATRY
- Schizophrenia severity and clozapine treatment outcome association with oxytocinergic genes
- (2010) Renan P. Souza et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Variants in the oxytocin gene and risk for schizophrenia
- (2010) Renan P. Souza et al. SCHIZOPHRENIA RESEARCH
- Peripheral oxytocin is associated with reduced symptom severity in schizophrenia
- (2010) Leah H. Rubin et al. SCHIZOPHRENIA RESEARCH
- Antipsychotic Dose Equivalents and Dose-Years: A Standardized Method for Comparing Exposure to Different Drugs
- (2009) Nancy C. Andreasen et al. BIOLOGICAL PSYCHIATRY
- The mechanism of life-threatening water imbalance in schizophrenia and its relationship to the underlying psychiatric illness
- (2009) Morris B. Goldman BRAIN RESEARCH REVIEWS
- Oxytocin, vasopressin, and human social behavior
- (2009) Markus Heinrichs et al. FRONTIERS IN NEUROENDOCRINOLOGY
- Vasopressin 1b Receptor Knock-Out Impairs Memory for Temporal Order
- (2009) L. M. DeVito et al. JOURNAL OF NEUROSCIENCE
- The Brattleboro Rat Displays a Natural Deficit in Social Discrimination That Is Restored by Clozapine and A Neurotensin Analog
- (2009) D Feifel et al. NEUROPSYCHOPHARMACOLOGY
- Facial emotion recognition in bipolar disorder: a critical review
- (2009) Cristiana Castanho de Almeida Rocca et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- The Other-Race Effect in Face Processing Among African American and Caucasian Individuals With Schizophrenia
- (2008) Amy E. Pinkham et al. AMERICAN JOURNAL OF PSYCHIATRY
- Cognitive endophenotypes of bipolar disorder: A meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives
- (2008) Emre Bora et al. JOURNAL OF AFFECTIVE DISORDERS
- Norms and standardization of the Brief Assessment of Cognition in Schizophrenia (BACS)
- (2008) R KEEFE et al. SCHIZOPHRENIA RESEARCH
- Sharing secrets: Oxytocin and trust in schizophrenia
- (2008) Szabolcs Kéri et al. Social Neuroscience
- Diminished plasma oxytocin in schizophrenic patients with neuroendocrine dysfunction and emotional deficits
- (2007) Morris Goldman et al. SCHIZOPHRENIA RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started